scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10875-014-0008-5 |
P698 | PubMed publication ID | 24659206 |
P2093 | author name string | Geeta Rai | |
Richa Rai | |||
Madhukar Rai | |||
Sudhir Kumar Chauhan | |||
Vikas Vikram Singh | |||
P2860 | cites work | Identification of novel AR-targeted microRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancer | Q21133676 |
Identification of unique microRNA signature associated with lupus nephritis | Q21136392 | ||
MicroRNA targeting specificity in mammals: determinants beyond seed pairing | Q24607724 | ||
ESCRT-III protein requirements for HIV-1 budding | Q24627115 | ||
p53 represses c-Myc through induction of the tumor suppressor miR-145 | Q24644779 | ||
Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence | Q24648180 | ||
MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways | Q24650451 | ||
miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. | Q24653347 | ||
Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression | Q24681466 | ||
Endophilins interact with Moloney murine leukemia virus Gag and modulate virion production | Q24799654 | ||
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus | Q28212039 | ||
Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling | Q28297583 | ||
Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks | Q28474080 | ||
Zcchc11-dependent uridylation of microRNA directs cytokine expression | Q28511274 | ||
Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression | Q28585012 | ||
Metabolic disturbances associated with systemic lupus erythematosus | Q28728267 | ||
Specificity of microRNA target selection in translational repression | Q28776123 | ||
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
Gene expression profiles in a rabbit model of systemic lupus erythematosus autoantibody production | Q30496834 | ||
Sex-different and growth hormone-regulated expression of microRNA in rat liver | Q30858748 | ||
Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. | Q33377575 | ||
Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus | Q33384708 | ||
MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells | Q33734042 | ||
Cytokine networks in systemic lupus erythematosus | Q33803103 | ||
Meta-analysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear cells | Q33915692 | ||
Dendritic cells in systemic lupus erythematosus | Q33941433 | ||
Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus | Q33993288 | ||
Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus | Q34061131 | ||
Distinct requirements of microRNAs in NK cell activation, survival, and function | Q34148095 | ||
The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells | Q34267599 | ||
Identification of microRNA transcriptome involved in human natural killer cell activation | Q34305912 | ||
Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a | Q34967479 | ||
MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta | Q35011103 | ||
MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis | Q35091092 | ||
Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro | Q35108358 | ||
Sex hormones and systemic lupus erythematosus: review and meta-analysis | Q35194931 | ||
Deranged bioenergetics and defective redox capacity in T lymphocytes and neutrophils are related to cellular dysfunction and increased oxidative stress in patients with active systemic lupus erythematosus | Q35326330 | ||
Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus | Q35554492 | ||
Autoimmune targeting of key components of RNA interference | Q35605638 | ||
Cytokine disturbances in systemic lupus erythematosus | Q35617573 | ||
MicroRNA-deficient NK cells exhibit decreased survival but enhanced function | Q35850882 | ||
Systemic lupus erythematosus serum deposits C4d on red blood cells, decreases red blood cell membrane deformability, and promotes nitric oxide production | Q35906840 | ||
Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosus | Q36206615 | ||
MicroRNA function in animal development | Q36235770 | ||
A nuclear antigen associated with cell proliferation and blast transformation | Q36346006 | ||
RNA integrity and the effect on the real-time qRT-PCR performance | Q36392323 | ||
Epstein-Barr virus infection induces lupus autoimmunity. | Q36661149 | ||
Estrogens and autoimmune diseases | Q36721822 | ||
Hepatitis B viral RNA directly mediates down-regulation of the tumor suppressor microRNA miR-15a/miR-16-1 in hepatocytes | Q36947870 | ||
microRNAs and the immune response | Q37178538 | ||
Cell-to-cell miRNA transfer: from body homeostasis to therapy | Q38035713 | ||
Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression | Q38334975 | ||
miR-451 regulates dendritic cell cytokine responses to influenza infection. | Q39241429 | ||
Herpes simplex virus UL56 interacts with and regulates the Nedd4-family ubiquitin ligase Itch. | Q39672120 | ||
Low plasma androgens in women with systemic lupus erythematosus | Q41331741 | ||
Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. | Q51570125 | ||
MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIα. | Q52712080 | ||
Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. | Q53718320 | ||
Cytokine production, serum levels and disease activity in systemic lupus erythematosus | Q57351067 | ||
Alterations of estrogen metabolism in systemic lupus erythematosus | Q57665882 | ||
Differential abnormality in cell-cycle stage of peripheral B cells from patients with systemic lupus erythematosus | Q68825704 | ||
Serum levels of interferons in patients with systemic lupus erythematosus | Q69018287 | ||
Distribution of the 70K U1 RNA-associated protein during interphase and mitosis. Correlation with other U RNP particles and proteins of the nuclear matrix | Q70038175 | ||
Abnormal estrogen and androgen metabolism in the human with systemic lupus erythematosus | Q70420002 | ||
Low plasma androgens in women with active or quiescent systemic lupus erythematosus | Q70569842 | ||
Impaired natural killer cell function in systemic lupus erythematosus. Relationship to interleukin-2 production | Q70996845 | ||
Incidence and clinical significance of anti-ENA antibodies in systemic lupus erythematosus. Estimation by counterimmunoelectrophoresis | Q71007155 | ||
Cellular DNA content of T helper, T suppressor and B lymphocytes in SLE | Q72824887 | ||
Design peptide scaffolds for regenerative medicine | Q73769899 | ||
Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus | Q74628846 | ||
Systemic lupus erythematosus disease activity index 2000 | Q77624632 | ||
Interferon-alpha and interleukin-6 in SLE serum induce the differentiation and maturation of dendritic cells derived from CD34+ hematopoietic precursor cells | Q83372669 | ||
MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins | Q83586463 | ||
Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation | Q86553655 | ||
P433 | issue | 4 | |
P921 | main subject | systemic lupus erythematosus | Q1485 |
microRNA | Q310899 | ||
autoantibody | Q785022 | ||
P304 | page(s) | 491-503 | |
P577 | publication date | 2014-05-01 | |
P1433 | published in | Journal of Clinical Immunology | Q6294961 |
P1476 | title | Differential microRNA profile and post-transcriptional regulation exist in systemic lupus erythematosus patients with distinct autoantibody specificities | |
P478 | volume | 34 |
Q37159985 | 'Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients' |
Q37402436 | Activation of TLR7 increases CCND3 expression via the downregulation of miR-15b in B cells of systemic lupus erythematosus |
Q49966463 | Diagnostic and prognostic tests in systemic lupus erythematosus |
Q36524673 | Epigenetics in systemic lupus erythematosus |
Q38549867 | Microarray to deep sequencing: transcriptome and miRNA profiling to elucidate molecular pathways in systemic lupus erythematosus |
Q36190001 | RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities |
Q58552569 | Rabbit models of human diseases for diagnostics and therapeutics development |
Q64236982 | Specific Autoantibodies and Clinical Phenotypes Correlate with the Aberrant Expression of Immune-Related MicroRNAs in Dermatomyositis |
Q54211938 | The Function of MicroRNAs in B-Cell Development, Lymphoma, and Their Potential in Clinical Practice. |
Q55012595 | The Involvement of MicroRNAs in Modulation of Innate and Adaptive Immunity in Systemic Lupus Erythematosus and Lupus Nephritis. |
Q35930798 | The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity. |
Q92350333 | Trained Innate Immunity Not Always Amicable |
Q28083028 | miRNAs in the Pathogenesis of Systemic Lupus Erythematosus |
Search more.